Suppressing PARylation by 2',5'-oligoadenylate synthetase 1 inhibits DNA damage-induced cell death.


Journal

The EMBO journal
ISSN: 1460-2075
Titre abrégé: EMBO J
Pays: England
ID NLM: 8208664

Informations de publication

Date de publication:
02 06 2020
Historique:
received: 16 01 2019
revised: 05 03 2020
accepted: 12 03 2020
pubmed: 24 4 2020
medline: 7 4 2021
entrez: 24 4 2020
Statut: ppublish

Résumé

High expression of 2',5'-oligoadenylate synthetase 1 (OAS1), which adds AMP residues in 2',5' linkage to a variety of substrates, is observed in many cancers as a part of the interferon-related DNA damage resistance signature (IRDS). Poly(ADP-ribose) (PAR) is rapidly synthesized from NAD

Identifiants

pubmed: 32323871
doi: 10.15252/embj.2019101573
pmc: PMC7265237
doi:

Substances chimiques

Adenosine Monophosphate 415SHH325A
OAS1 protein, human EC 2.7.7.-
2',5'-Oligoadenylate Synthetase EC 2.7.7.84

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e101573

Subventions

Organisme : NIH HHS
ID : S10 OD019972
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI135922
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA062220
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2020 The Authors.

Références

EMBO J. 2020 Jun 2;39(11):e101573
pubmed: 32323871
PLoS One. 2012;7(10):e47978
pubmed: 23110147
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):3949-54
pubmed: 25775560
Biochimie. 2012 May;94(5):1098-107
pubmed: 22285541
Cancer Res. 2007 Oct 1;67(19):9214-20
pubmed: 17909027
Genes Dev. 2017 Jan 15;31(2):101-126
pubmed: 28202539
Free Radic Biol Med. 1997;22(1-2):73-83
pubmed: 8958131
Methods Mol Biol. 2013;942:291-314
pubmed: 23027058
BMC Cell Biol. 2014 Sep 09;15:33
pubmed: 25205466
Cell Rep. 2014 Sep 25;8(6):1819-1831
pubmed: 25220464
Biochem Pharmacol. 2014 Nov 1;92(1):157-63
pubmed: 24976506
Nucleic Acids Res. 2015 Apr 30;43(8):4028-38
pubmed: 25813046
Curr Mol Pharmacol. 2012 Jan;5(1):102-14
pubmed: 22122467
Proc Natl Acad Sci U S A. 1978 Jan;75(1):256-60
pubmed: 272640
Exp Neurol. 2009 Aug;218(2):193-202
pubmed: 19332058
J Biol Chem. 1984 Feb 10;259(3):1731-7
pubmed: 6319408
Brain Res. 2010 Jul 9;1343:206-12
pubmed: 20451505
Sci Rep. 2015 Nov 02;5:15798
pubmed: 26522181
Exp Cell Res. 1998 Mar 15;239(2):379-92
pubmed: 9521856
J Immunol. 2009 Dec 15;183(12):8035-43
pubmed: 19923450
EMBO J. 2013 Oct 16;32(20):2751-63
pubmed: 24065129
Genes Dev. 2012 Mar 1;26(5):417-32
pubmed: 22391446
FEBS Lett. 1986 Feb 3;196(1):113-20
pubmed: 3753689
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18308-13
pubmed: 17116882
Pharmacol Ther. 1998 May;78(2):55-113
pubmed: 9623881
J Interferon Cytokine Res. 2011 Jan;31(1):41-7
pubmed: 21142819
Cell Mol Life Sci. 2014 Jan;71(2):331-48
pubmed: 23760205
Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):363-71
pubmed: 17698400
Biochem Biophys Res Commun. 1981 May 29;100(2):847-56
pubmed: 6268077
Cell Res. 2012 Jul;22(7):1181-98
pubmed: 22525338
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18490-5
pubmed: 19001271
Curr Protein Pept Sci. 2016;17(7):654-667
pubmed: 27090904
Cell Mol Life Sci. 2007 Jul;64(14):1793-800
pubmed: 17514354
Br J Pharmacol. 2014 Apr;171(8):2000-16
pubmed: 24684389
Cell. 2017 Feb 9;168(4):644-656
pubmed: 28187286
Cancer Res. 2017 Apr 1;77(7):1709-1718
pubmed: 28202508
Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1652-7
pubmed: 23319625
Autophagy. 2009 Jan;5(1):61-74
pubmed: 19001878
J Pharmacol Exp Ther. 2007 Apr;321(1):318-26
pubmed: 17202402
J Biochem. 2014 Aug;156(2):85-95
pubmed: 24682951
Viruses. 2020 Jan 29;12(2):
pubmed: 32013110
Mol Biol Evol. 2000 May;17(5):738-50
pubmed: 10779534
mBio. 2014 Jul 01;5(4):e01312-14
pubmed: 24987090
J Biol Chem. 1987 Mar 15;262(8):3852-7
pubmed: 2434505
Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1714-9
pubmed: 14755057
Nat Commun. 2019 Mar 12;10(1):1182
pubmed: 30862789
Eur J Biochem. 1982 Mar 1;122(3):601-8
pubmed: 6277637
J Biol Chem. 1990 Oct 25;265(30):18601-7
pubmed: 2211721
Mol Cell. 2015 Jun 18;58(6):935-46
pubmed: 26091342
J Virol. 2003 Apr;77(7):4273-82
pubmed: 12634384
Science. 2016 Oct 7;354(6308):
pubmed: 27846469
J Cell Sci. 2016 Oct 15;129(20):3845-3858
pubmed: 27587838
J Biol Chem. 1999 Sep 3;274(36):25535-42
pubmed: 10464285
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2241-6
pubmed: 26858407
Cell Death Differ. 2012 Dec;19(12):2003-14
pubmed: 22814620
Genes Dev. 2005 Sep 1;19(17):1951-67
pubmed: 16140981
Carcinogenesis. 1999 May;20(5):851-7
pubmed: 10334203
Br J Pharmacol. 2018 Jan;175(2):192-222
pubmed: 28213892
Am J Hum Genet. 2005 Apr;76(4):623-33
pubmed: 15732009
J Biol Chem. 1995 Feb 24;270(8):4133-7
pubmed: 7876164
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:437-454
pubmed: 28061689
Nucleic Acids Res. 2006;34(22):6684-95
pubmed: 17145707
Nat Rev Mol Cell Biol. 2017 Oct;18(10):610-621
pubmed: 28676700
Mutat Res. 1990 Jul;231(1):11-30
pubmed: 2195323
J Virol. 2007 Dec;81(23):12720-9
pubmed: 17804500
Mol Cell. 2015 Dec 3;60(5):742-754
pubmed: 26626479
Nat Rev Mol Cell Biol. 2014 Aug;15(8):509-24
pubmed: 25027649
Mol Aspects Med. 2013 Dec;34(6):1153-67
pubmed: 23416893
Ann Oncol. 2014 Jan;25(1):32-40
pubmed: 24225019
J Biol Chem. 1980 Jun 10;255(11):5031-5
pubmed: 6154699
J Interferon Cytokine Res. 1999 Apr;19(4):295-308
pubmed: 10334380
Nucleic Acids Res. 2014 Aug;42(14):9108-20
pubmed: 25074383
Mol Cell. 2019 Feb 21;73(4):845-856.e5
pubmed: 30712989
Cell Death Differ. 2007 May;14(5):1001-10
pubmed: 17218956
Viruses. 2019 Dec 04;11(12):
pubmed: 31817188
J Toxicol Environ Health. 1988;23(3):407-23
pubmed: 3351984
Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5071-5076
pubmed: 30814222

Auteurs

Anna A Kondratova (AA)

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of Psychiatry, Case Western Reserve University, Cleveland, OH, USA.

HyeonJoo Cheon (H)

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Beihua Dong (B)

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Elise G Holvey-Bates (EG)

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Metis Hasipek (M)

Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.

Irina Taran (I)

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Christina Gaughan (C)

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Babal K Jha (BK)

Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.

Robert H Silverman (RH)

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

George R Stark (GR)

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH